OUTLOOK THERAPEUTICS INC (OTLK)

Currency in USD
1.880
-0.120(-6.00%)
Closed·
After Hours
1.860-0.020(-1.06%)
·
OTLK Scorecard
Full Analysis
Suffers from weak gross profit margins
OTLK is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.8512.000
52 wk Range
0.8708.320
Key Statistics
Prev. Close
2
Open
1.98
Day's Range
1.851-2
52 wk Range
0.87-8.32
Volume
1.49M
Average Volume (3m)
852.45K
1-Year Change
-71.63%
Book Value / Share
-1
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
OTLK Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
8.600
Upside
+357.45%
Members' Sentiments
Bearish
Bullish
ProTips
Short term obligations exceed liquid assets

OUTLOOK THERAPEUTICS INC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

OUTLOOK THERAPEUTICS INC Company Profile

Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic bevacizumab product formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration agreements with Cencora. The company was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. Outlook Therapeutics, Inc. was incorporated in 2010 and is headquartered in Iselin, New Jersey.

Compare OTLK to Peers and Sector

Metrics to compare
OTLK
Peers
Sector
Relationship
P/E Ratio
3.8x−3.5x−0.5x
PEG Ratio
0.04−0.010.00
Price/Book
−2.5x2.6x2.6x
Price / LTM Sales
-161.8x3.3x
Upside (Analyst Target)
302.0%183.7%42.8%
Fair Value Upside
Unlock−0.2%6.5%Unlock

Analyst Ratings

4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 8.600
(+357.45% Upside)

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-1.50 / -0.06
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

OTLK Income Statement

People Also Watch

16.24
SRPT
-3.04%
51.750
ASTS
-1.56%
1.890
OPEN
-25.00%
14.34
OSCR
+3.76%
25.21
CNC
-2.63%

FAQ

What Stock Exchange Does OUTLOOK THERAPEUTICS Trade On?

OUTLOOK THERAPEUTICS is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for OUTLOOK THERAPEUTICS?

The stock symbol for OUTLOOK THERAPEUTICS is "OTLK."

What Is the OUTLOOK THERAPEUTICS Market Cap?

As of today, OUTLOOK THERAPEUTICS market cap is 80.78M.

What Is OUTLOOK THERAPEUTICS's Earnings Per Share (TTM)?

The OUTLOOK THERAPEUTICS EPS (TTM) is 0.83.

From a Technical Analysis Perspective, Is OTLK a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has OUTLOOK THERAPEUTICS Stock Split?

OUTLOOK THERAPEUTICS has split 2 times.

How Many Employees Does OUTLOOK THERAPEUTICS Have?

OUTLOOK THERAPEUTICS has 23 employees.

What is the current trading status of OUTLOOK THERAPEUTICS (OTLK)?

As of 06 Aug 2025, OUTLOOK THERAPEUTICS (OTLK) is trading at a price of 1.88, with a previous close of 2.00. The stock has fluctuated within a day range of 1.85 to 2.00, while its 52-week range spans from 0.87 to 8.32.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.